Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDProfound Medical Corp. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 3 | -$0.42 | -$0.38 | -$0.40 |
| Q2 2025 | 1 | -$0.39 | -$0.39 | -$0.39 |
| Q3 2025 | 1 | -$0.39 | -$0.39 | -$0.39 |
| Q4 2025 | 1 | -$0.34 | -$0.34 | -$0.34 |
| Q1 2026 | 1 | -$0.35 | -$0.35 | -$0.35 |
| Q2 2026 | 1 | -$0.29 | -$0.29 | -$0.29 |
| Q3 2026 | 1 | -$0.27 | -$0.27 | -$0.27 |
| Q4 2026 | 1 | -$0.20 | -$0.20 | -$0.20 |
Profound Medical Corp. Earnings Date And Information
Profound Medical Corp. last posted its earnings results on Thursday, March 6th, 2025. The company reported $-0.2 earnings per share for the quarter, topping analysts' consensus estimates of $-0.31 by $0.11. The company had revenue of 2,963 for the quarter and had revenue of 10.68 M for the year. Profound Medical Corp. has generated $1 earnings per share over the last year ($1.12 diluted earnings per share) and currently has a price-to-earnings ratio of -4.64. Profound Medical Corp. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 7th, 2025 based on prior year's report dates.
Profound Medical Corp. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/07/2025 | Q4 2024 | N/A | $0.00 | N/A | $4.23 M | $2,963 |
| 11/07/2024 | Q3 2024 | -$0.33 | -$0.38 | -0.05 | $3.00 M | $2.83 M |
| 06/29/2024 | Q2 2024 | N/A | -$0.28 | N/A | $2.64 M | $2.23 M |
| 03/30/2024 | Q1 2024 | N/A | -$0.26 | N/A | $2.44 M | $1.91 M |
| 12/30/2023 | Q4 2023 | N/A | -$0.42 | N/A | $1.97 M | $2.01 M |
| 09/29/2023 | Q3 2023 | N/A | -$0.26 | N/A | $2.20 M | $1.73 M |
| 06/29/2023 | Q2 2023 | N/A | -$0.35 | N/A | $2.13 M | $1.60 M |
| 03/30/2023 | Q1 2023 | N/A | -$0.32 | N/A | $2.12 M | $1.86 M |
| 12/30/2022 | Q4 2022 | N/A | -$0.46 | N/A | $2.67 M | $1.26 M |
| 09/29/2022 | Q3 2022 | N/A | -$0.24 | N/A | $2.41 M | $2.04 M |
| 06/29/2022 | Q2 2022 | N/A | -$0.29 | N/A | $2.02 M | $2.03 M |
| 03/30/2022 | Q1 2022 | N/A | -$0.40 | N/A | $1.76 M | $1.36 M |
| 12/30/2021 | Q4 2021 | N/A | -$0.49 | N/A | $2.79 M | $998,000 |
| 09/29/2021 | Q3 2021 | N/A | -$0.29 | N/A | $3.57 M | $2.54 M |
| 06/29/2021 | Q2 2021 | N/A | -$0.35 | N/A | $2.20 M | $2.63 M |
| 03/30/2021 | Q1 2021 | N/A | -$0.37 | N/A | $2.48 M | $711,000 |
| 12/30/2020 | Q4 2020 | N/A | -$0.37 | N/A | $2.31 M | $2.85 M |
| 09/29/2020 | Q3 2020 | N/A | -$0.32 | N/A | $1.71 M | $2.23 M |
| 06/29/2020 | Q2 2020 | N/A | -$0.33 | N/A | $737,216 | $1.04 M |
| 03/30/2020 | Q1 2020 | N/A | -$0.17 | N/A | $892,288 | $1.10 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Profound Medical Corp. Earnings: FAQ's
Profound Medical Corp. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 7th, 2025 based offlast year's report dates.
In the previous quarter, Profound Medical Corp. (:PROF) reported $-0.2 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.31 by $0.11.
The conference call for Profound Medical Corp.'s latest earnings report can be listened to online.
The conference call transcript for Profound Medical Corp.'s latest earnings report can be read online.
Profound Medical Corp. (:PROF) has a recorded annual revenue of $10.68 M.
Profound Medical Corp. (:PROF) has a recorded net income of $-27,816,000.Profound Medical Corp. has generated $1.12 earnings per share over the last four quarters.
Profound Medical Corp. (:PROF) has a price-to-earnings ratio of -4.64 and price/earnings-to-growth ratio is -0.3.